1 results match your criteria: "Hospital Luis Sanchez Bulnes IAP[Affiliation]"
Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity.
Br J Ophthalmol
July 2013
Department of Ophthalmology, Asociación para Evitar Ceguera en México, Hospital Luis Sanchez Bulnes IAP, Mexico City, Mexico.
Purpose: To evaluate ocular outcome in premature infants treated with intravitreal ranibizumab injections for retinopathy of prematurity (ROP) over a period of 3 years.
Methods: An interventional case series. Premature infants with high-risk prethreshold or threshold ROP with plus disease received an off label monotherapy with intravitreal injections of ranibizumab.